Skip to main content
. Author manuscript; available in PMC: 2012 Feb 15.
Published in final edited form as: Int J Cancer. 2011 Feb 15;128(4):951–961. doi: 10.1002/ijc.25410

Figure 5.

Figure 5

(A) The effects of dasatinib and/or curcumin on regression of intestinal tumors in ApcMin+/− mice. (B) Effects of dasatinib and/or curcumin on proliferation and apoptosis in the tissue remnants from adenomas.